Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PEAQX (NVP-AAM077)(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 46.00 | |
2 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 117.00 | |
10 mg | In stock | $ 211.00 | |
25 mg | In stock | $ 380.00 | |
50 mg | In stock | $ 591.00 | |
100 mg | In stock | $ 843.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 167.00 |
Description | PEAQX (NVP-AAM077)(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM). |
Targets&IC50 | PEAQX(NVP-AAM 077) is an effective and orally available human NMDA receptors for 1A/2A:270 nM |
Synonyms | NVP-AAM077 |
Molecular Weight | 454.21 |
Formula | C17H17BrN3O5P |
CAS No. | 459836-30-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6 mg/mL (13.21 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PEAQX 459836-30-7 Membrane transporter/Ion channel Neuroscience NMDAR iGluR Inhibitor Ionotropic glutamate receptors inhibit NVP-AAM 077 NVP-AAM077 NVP-AAM-077 inhibitor